Most kidney patients are focused on creatinine while almost nobody is talking about what's happening inside the kidney cells. That's where NAC and ALA become interesting. Because kidney disease is not just Kidney injury detection with biomarkers and the NIR II Photon etc. Glutathione specific gammaglutamylcyclotransferase 1 (CHAC1) increases kidney disease risk by modulating ferroptosis Science Translational Medicine Frontiers Glutathione: Pharmacological aspects and implications for clinical use in non alcoholic fatty liver disease Glutathione: Benefits and Supplements Glutathione an overview ScienceDirect Topics